The role of ethnicity in treatment refractory schizophrenia

Comprehensive Psychiatry

Volumn 54, Issue 2, 2013, Pages 167-172

  Teo, Celine ^a   Borlido, Carol ^a   Kennedy, James L ^a   De Luca, Vincenzo ^a  

^a CENTRE FOR ADDICTION AND MENTAL HEALTH   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CLOZAPINE; NEUROLEPTIC AGENT;

ADULT; ARTICLE; CANADA; DISEASE DURATION; DSM-IV; ETHNIC DIFFERENCE; ETHNICITY; EUROPEAN AMERICAN; FEMALE; HOSPITAL ADMISSION; HUMAN; MAJOR CLINICAL STUDY; MALE; PARANOID SCHIZOPHRENIA; POLYPHARMACY; SCHIZOAFFECTIVE PSYCHOSIS; SCHIZOPHRENIA; SUICIDE ATTEMPT; THERAPY RESISTANCE; TREATMENT FAILURE; TREATMENT RESPONSE; UNSPECIFIED SIDE EFFECT;

ADULT; ANTIPSYCHOTIC AGENTS; CANADA; CLOZAPINE; FEMALE; HUMANS; MALE; MIDDLE AGED; POLYPHARMACY; RISPERIDONE; SCHIZOPHRENIA; SEX FACTORS; TREATMENT FAILURE;

EID: 84872779679     PISSN: 0010440X     EISSN: 15328384     Source Type: Journal    
DOI: 10.1016/j.comppsych.2012.07.002     Document Type: Article

References (34)

1. R.R. Conley, and R.W. Buchanan Evaluation of treatment-resistant schizophrenia Schizophr Bull 23 4 1997 663 674 (Pubitemid 27485974)
2. J.M. Davis, C.B. Schaffer, G.A. Killian, C. Kinard, and C. Chan Important issues in the drug treatment of schizophrenia Schizophr Bull 6 1 1980 70 87 (Pubitemid 10066395)
3. J. Lieberman, D. Jody, S. Geisler, J. Alvir, A. Loebel, and S. Szymanski Time course and biologic correlates of treatment response in first-episode schizophrenia Arch Gen Psychiatry 50 5 1993 369 376 (Pubitemid 23143126)
4. E.L. Weiss, J.G. Longhurst, and M.B. Bowers Jr. Mazure CM: Olanzapine for treatment-refractory psychosis in patients responsive to, but intolerant of, clozapine J Clin Psychopharmacol 19 4 1999 378 380 (Pubitemid 29344855)
5. A.P. Castro, and H. Elkis Rehospitalization rates of patients with schizophrenia discharged on haloperidol, risperidone or clozapine Rev Bras Psiquiatr 29 3 2007 207 212
6. J.A. Lieberman Prediction of outcome in first-episode schizophrenia J Clin Psychiatry 54 Suppl. 1993 13 17 (Pubitemid 23121851)
7. J.M. Kane, G. Honigfeld, J. Singer, and H. Meltzer Clozapine in treatment-resistant schizophrenics Psychopharmacol Bull 24 1 1988 62 67
8. S. Leucht, J.M. Davis, R.R. Engel, J.M. Kane, and S. Wagenpfeil Defining 'response' in antipsychotic drug trials: recommendations for the use of scale-derived cutoffs Neuropsychopharmacology 32 9 2007 1903 1910 (Pubitemid 47258518)
9. J.A. Lieberman, J.M. Alvir, A. Koreen, S. Geisler, M. Chakos, and B. Sheitman Psychobiologic correlates of treatment response in schizophrenia Neuropsychopharmacology 14 3 Suppl 1996 13S 21S (Pubitemid 26096725)
10. T.H. McGlashan, and J.O. Johannessen Early detection and intervention with schizophrenia: rationale Schizophr Bull 22 2 1996 201 222 (Pubitemid 26174570)
11. R.J. Wyatt Neuroleptics and the natural course of schizophrenia Schizophr Bull 17 2 1991 325 351
12. H. Meltzer, and A. Kostakoglu Treatment Resistant Schizophrenia J. Liberman, R. Murray, Comphrehensive Care of Schizophrenia: A Textbook of Clinical Management 2001 Martin Dunitz London 181 203
13. H.Y. Meltzer, and G. Okayli Reduction of suicidality during clozapine treatment of neuroleptic-resistant schizophrenia: impact on risk-benefit assessment Am J Psychiatry 152 2 1995 183 190
14. C.G. Crosthwaite, and M.A. Reveley Structural imaging and treatment response in schizophrenia M.A. Reveley, The psychopharmacology of schizophrenia 2000 Arnold London 89 108
15. L. Friedman, C. Lys, and S.C. Schulz The relationship of structural brain imaging parameters to antipsychotic treatment response: a review J Psychiatry Neurosci 17 2 1992 42 54 (Pubitemid 23141089)
16. T. Sharma, and R. Kerwin Biological determinants of difficult to treat patients with schizophrenia Br J Psychiatry Suppl 31 1996 5 9 (Pubitemid 26419542)
17. R. Burnett, R. Mallett, D. Bhugra, G. Hutchinson, G. Der, and J. Leff The first contact of patients with schizophrenia with psychiatric services: social factors and pathways to care in a multi-ethnic population Psychol Med 29 2 1999 475 483 (Pubitemid 29129332)
18. C. Morgan, R. Mallett, G. Hutchinson, H. Bagalkote, K. Morgan, and P. Fearon Pathways to care and ethnicity. 2: Source of referral and help-seeking. Report from the AESOP study Br J Psychiatry 186 2005 290 296 (Pubitemid 40524006)
19. S.P. Singh, and T. Grange Measuring pathways to care in first-episode psychosis: a systematic review Schizophr Res 81 1 2006 75 82 (Pubitemid 41817208)
20. S. Archie, N. Akhtar-Danesh, R. Norman, A. Malla, P. Roy, and R.B. Zipursky Ethnic diversity and pathways to care for a first episode of psychosis in Ontario Schizophr Bull 36 4 2010 688 701
21. E. Cantor-Graae, and J.P. Selten Schizophrenia and migration: a meta-analysis and review Am J Psychiatry 162 1 2005 12 24 (Pubitemid 40095666)
22. A.F. Lehman, J.A. Lieberman, L.B. Dixon, T.H. McGlashan, A.L. Miller, and D.O. Perkins Practice guideline for the treatment of patients with schizophrenia, second edition Am J Psychiatry 161 2 Suppl 2004 1 56
23. J. Henna Neto, and H. Elkis Clinical aspects of super-refractory schizophrenia: a 6-month cohort observational study Rev Bras Psiquiatr 29 3 2007 228 232
24. H.Y. Meltzer, J. Rabinowitz, M.A. Lee, P.A. Cola, R. Ranjan, and R.L. Findling Age at onset and gender of schizophrenic patients in relation to neuroleptic resistance Am J Psychiatry 154 4 1997 475 482 (Pubitemid 27147599)
25. D.C. Goff, and O. Freudenreich Focus on polypharmacy in schizophrenia: does anyone truly benefit? Int J Neuropsychopharmacol 7 2 2004 109 111 (Pubitemid 38823276)
26. S.M. Stahl Antipsychotic polypharmacy: squandering precious resources? J Clin Psychiatry 63 2 2002 93 94 (Pubitemid 34173843)
27. J. Ananth, S. Parameswaran, and S. Gunatilake Antipsychotic polypharmacy Curr Pharm Des 10 18 2004 2231 2238 (Pubitemid 38832765)
28. A.F. Lehman, and D.M. Steinwachs Patterns of usual care for schizophrenia: initial results from the Schizophrenia Patient Outcomes Research Team (PORT) client survey Schizophr Bull 24 1 1998 11 20 [discussion 20-32]
29. S.M. Strakowski, P.E. Keck Jr., L.M. Arnold, J. Collins, R.M. Wilson, and D.E. Fleck Ethnicity and diagnosis in patients with affective disorders J Clin Psychiatry 64 7 2003 747 754 (Pubitemid 36897209)
30. J.T. Walkup, D.D. McAlpine, M. Olfson, L.E. Labay, C. Boyer, and S. Hansell Patients with schizophrenia at risk for excessive antipsychotic dosing J Clin Psychiatry 61 5 2000 344 348 (Pubitemid 30345935)
31. P. Ruiz, R.V. Varner, D.R. Small, and B.A. Johnson Ethnic differences in the neuroleptic treatment of schizophrenia Psychiatr Q 70 2 1999 163 172 (Pubitemid 29283669)
32. L.M. Arnold, S.M. Strakowski, M.L. Schwiers, J. Amicone, D.E. Fleck, and K.B. Corey Sex, ethnicity, and antipsychotic medication use in patients with psychosis Schizophr Res 66 2-3 2004 169 175 (Pubitemid 38041116)
33. W.V. Bobo, K. Jayathilake, M.A. Lee, and H.Y. Meltzer Changes in weight and body mass index during treatment with melperone, clozapine and typical neuroleptics Psychiatry Res 176 2-3 2010 114 119
34. M.D. Orfei, I. Spoletini, G. Banfi, C. Caltagirone, and G. Spalletta Neuropsychological correlates of cognitive insight in schizophrenia Psychiatry Res 178 1 2010 51 56